Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369)

João Glasberg; Aley Talans; Thomás Rivelli Giollo; Débora Zachello Recchimuzzi; João Evangelista Bezerra Neto; Rossana Veronica Mendonza Lopez; Paulo Marcelo Gehm Hoff; Rachel P. Riechelmann

doi:10.3332/ecancer.2022.1421

Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369)

João Glasberg, Aley Talans, Thomás Rivelli Giollo, Débora Zachello Recchimuzzi, João Evangelista Bezerra Neto, Rossana Veronica Mendonza Lopez, Paulo Marcelo Gehm Hoff, Rachel P. Riechelmann

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Thomás Rivelli Giollo is corrected to Thomás Giollo Rivelli.

Original language	English (US)
Article number	1421
Journal	ecancermedicalscience
Volume	16
DOIs	https://doi.org/10.3332/ecancer.2022.1421
State	Published - 2022
Externally published	Yes

Keywords

cancer treatment
metformin
neuroendocrine tumours

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3332/ecancer.2022.1421

Cite this

Glasberg, J., Talans, A., Giollo, T. R., Recchimuzzi, D. Z., Neto, J. E. B., Lopez, R. V. M., Hoff, P. M. G., & Riechelmann, R. P. (2022). Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369). ecancermedicalscience, 16, Article 1421. https://doi.org/10.3332/ecancer.2022.1421

@article{49e8004701a4412f81832abdbce6cb90,

title = "Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369)",

abstract = "Thom{\'a}s Rivelli Giollo is corrected to Thom{\'a}s Giollo Rivelli.",

keywords = "cancer treatment, metformin, neuroendocrine tumours",

author = "Jo{\~a}o Glasberg and Aley Talans and Giollo, {Thom{\'a}s Rivelli} and Recchimuzzi, {D{\'e}bora Zachello} and Neto, {Jo{\~a}o Evangelista Bezerra} and Lopez, {Rossana Veronica Mendonza} and Hoff, {Paulo Marcelo Gehm} and Riechelmann, {Rachel P.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2022",

doi = "10.3332/ecancer.2022.1421",

language = "English (US)",

volume = "16",

journal = "ecancermedicalscience",

issn = "1754-6605",

publisher = "Cancer Intellilgence",

}

TY - JOUR

T1 - Erratum

T2 - METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369)

AU - Glasberg, João

AU - Talans, Aley

AU - Giollo, Thomás Rivelli

AU - Recchimuzzi, Débora Zachello

AU - Neto, João Evangelista Bezerra

AU - Lopez, Rossana Veronica Mendonza

AU - Hoff, Paulo Marcelo Gehm

AU - Riechelmann, Rachel P.

PY - 2022

Y1 - 2022

N2 - Thomás Rivelli Giollo is corrected to Thomás Giollo Rivelli.

AB - Thomás Rivelli Giollo is corrected to Thomás Giollo Rivelli.

KW - cancer treatment

KW - metformin

KW - neuroendocrine tumours

UR - http://www.scopus.com/inward/record.url?scp=85140226021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140226021&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2022.1421

DO - 10.3332/ecancer.2022.1421

M3 - Comment/debate

C2 - 36158978

AN - SCOPUS:85140226021

SN - 1754-6605

VL - 16

JO - ecancermedicalscience

JF - ecancermedicalscience

M1 - 1421

ER -

Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (ecancer (2022) 16:1369 DOI:10.3332/ecancer.2022.1369)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this